Opportunistic infections and biologic therapies in immune-mediated inflammatory diseases: Consensus recommendations for infection reporting during clinical trials and postmarketing surveillance

K. L. Winthrop, S. A. Novosad, J. W. Baddley, L. Calabrese, T. Chiller, P. Polgreen, F. Bartalesi, M. Lipman, X. Mariette, O. Lortholary, M. E. Weinblatt, M. Saag, J. Smolen

Research output: Contribution to journal › Review article › peer-review

107 Scopus citations

Fingerprint

Dive into the research topics of 'Opportunistic infections and biologic therapies in immune-mediated inflammatory diseases: Consensus recommendations for infection reporting during clinical trials and postmarketing surveillance'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds